A Multicomponent Intervention to Address Gender-based Violence in HIV

Status Completed

Clinical Trial Summary

This project seeks to adapt and pilot a trauma-informed combination intervention named 'Kickin' it with the Gurlz' that was designed with, for, and by transgender women of color to improve HIV prevention continuum outcomes. The intervention components include a violence and gender affirmation screening tool, a peer-led adaptation of Seeking Safety, and individual-level peer navigation sessions. We will examine the feasibility, acceptability, and preliminary promise of the multicomponent by conducting a one-arm pilot with 30 transgender women of color who have a history of trauma. Participants will complete baseline, immediate post-intervention, and 3-month follow up assessments.

Clinical Trial Description

This project seeks to evaluate the feasibility and acceptability of the trauma-informed combination prevention intervention to improve HIV prevention continuum outcomes including the development of community-informed strategies for subsequent RCTs. We will conduct a one-arm pilot of the adapted multicomponent trauma-informed intervention named "Kickin it with the Gurlz." We will collect feasibility and acceptability data related to identifying, recruiting, enrolling, intervening with, and retaining participants (i.e. recruitment length, screening procedures, feasibility of conducting sessions, intervention acceptability, retention rates, feasibility of verifying self-reported and medical chart review data on PrEP use, and exit interviews with participants and staff at program conclusion). We will recruit 30 participants into the pilot study. Participants will complete baseline, end of program, and 3-month post-intervention follow-up surveys. Exit interviews and interviews with key stakeholders will identify strategies for implementing trauma-informed HIV prevention efficacy trials with transgender women of color within close-knit communities, such as acceptable and feasible control conditions, acceptable and feasible violence and gender affirmation screening, biomedical confirmation methods, contamination concerns, and potential changes needed within existing health care systems. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04799197
Study type	Interventional
Source	University of Michigan
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2021
Completion date	May 15, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06024083` - Skills Video Intervention for Chinese/Chinese Americans	N/A
Completed	`NCT04150354` - Mental Health Symptom Monitoring Utilizing the Cogito Behavioral Analytic Platform	N/A
Active, not recruiting	`NCT06175520` - Introduction of Preconception Care Through Public Health System for Improving MNCH&FP	N/A
Recruiting	`NCT05121428` - Patients' Attitudes Toward and Experiences With Buprenorphine Treatment
Completed	`NCT04881643` - Blended Treatment för PTSD Feasibility Study	N/A
Not yet recruiting	`NCT05835635` - Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
Completed	`NCT04614220` - The Correlation Between Family Member Presence and The Consent for Regional Anaesthesia for Caesarean Section
Active, not recruiting	`NCT05458765` - Project Engage: Oral PrEP Acceptability	Phase 2
Not yet recruiting	`NCT06362837` - Evaluation of REACTS-IN, an Intervention to Improve Nutrition, Hygiene, and Sexual and Reproductive Health Services	N/A
Completed	`NCT04693585` - Development and Pilot Test of a Postnatal mHealth Intervention - Phase 2	N/A
Completed	`NCT04813484` - Addressing Violence and HIV Care Among Transgender Women	N/A
Recruiting	`NCT06136702` - ELEVATE Acceptability Study	N/A
Recruiting	`NCT05224154` - Re-Connect Application for Smoking Cessation	N/A
Completed	`NCT04636398` - Postnatal mHealth Intervention Development	N/A
Recruiting	`NCT06404632` - A Group Intervention for Promoting Health-related Habits (LEV-G)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.